1-3 of 3
Roger Owen
Close
Sort by
Journal Articles

Clinical characteristics and outcomes of IgD myeloma: experience across UK national trials

Clinical Trials & Observations
Charles Agbuduwe, Gulnaz Iqbal, David Cairns, Tom Menzies, Janet Dunn, Walter Gregory, Martin Kaiser, Roger Owen, Charlotte Pawlyn, J. Anthony Child, Faith Davies, Gareth J. Morgan, Graham H. Jackson, Mark T. Drayson, Supratik Basu
Journal: Blood Advances
Blood Adv (2022) 6 (17): 5113–5123.
https://doi.org/10.1182/bloodadvances.2022007608
Published: 2022
Includes: Supplemental data
Journal Articles

Pooled safety analysis of zanubrutinib monotherapy in patients with B-cell malignancies

Clinical Trials & Observations
Constantine S. Tam, Meletios Dimopoulos, Ramon Garcia-Sanz, Judith Trotman, Stephen Opat, Andrew W. Roberts, Roger Owen, Yuqin Song, Wei Xu, Jun Zhu, Jianyong Li, Lugui Qiu, Shirley D’Sa, Wojciech Jurczak, Gavin Cull, Paula Marlton, David Gottlieb, Javier Munoz, Tycel Phillips, Chenmu Du, Meng Ji, Lei Zhou, Haiyi Guo, Hongjie Zhu, Wai Y. Chan, Aileen Cohen, William Novotny, Jane Huang, Alessandra Tedeschi
Journal: Blood Advances
Blood Adv (2022) 6 (4): 1296–1308.
https://doi.org/10.1182/bloodadvances.2021005621
Published: 2022
Includes: Supplemental data
Journal Articles

TLR-mediated activation of Waldenström macroglobulinemia B cells reveals an uncoupling from plasma cell differentiation

Jennifer Shrimpton, Matthew A. Care, Jonathan Carmichael, Kieran Walker, Paul Evans, Charlotte Evans, Ruth de Tute, Roger Owen, Reuben M. Tooze, Gina M. Doody
Journal: Blood Advances
Blood Adv (2020) 4 (12): 2821–2836.
https://doi.org/10.1182/bloodadvances.2019001279
Published: 2020
Includes: Supplemental data